Armbruster Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $399K | Hold |
2,152
| – | – | 0.07% | 98 |
|
2025
Q1 | $451K | Hold |
2,152
| – | – | 0.09% | 90 |
|
2024
Q4 | $382K | Hold |
2,152
| – | – | 0.08% | 97 |
|
2024
Q3 | $425K | Buy |
2,152
+132
| +7% | +$26.1K | 0.08% | 94 |
|
2024
Q2 | $346K | Buy |
2,020
+122
| +6% | +$20.9K | 0.07% | 95 |
|
2024
Q1 | $346K | Hold |
1,898
| – | – | 0.07% | 88 |
|
2023
Q4 | $294K | Hold |
1,898
| – | – | 0.07% | 91 |
|
2023
Q3 | $283K | Hold |
1,898
| – | – | 0.07% | 88 |
|
2023
Q2 | $256K | Buy |
1,898
+488
| +35% | +$65.7K | 0.06% | 95 |
|
2023
Q1 | $225K | Hold |
1,410
| – | – | 0.06% | 99 |
|
2022
Q4 | $228K | Buy |
+1,410
| New | +$228K | 0.06% | 98 |
|
2022
Q3 | – | Sell |
-1,410
| Closed | -$216K | – | 106 |
|
2022
Q2 | $216K | Hold |
1,410
| – | – | 0.06% | 108 |
|
2022
Q1 | $229K | Buy |
+1,410
| New | +$229K | 0.06% | 118 |
|
2018
Q2 | – | Sell |
-600
| Closed | -$57K | – | 70 |
|
2018
Q1 | $57K | Sell |
600
-74
| -11% | -$7.03K | 0.03% | 122 |
|
2017
Q4 | $65K | Hold |
674
| – | – | 0.03% | 113 |
|
2017
Q3 | $60K | Sell |
674
-354
| -34% | -$31.5K | 0.03% | 115 |
|
2017
Q2 | $75K | Buy |
1,028
+65
| +7% | +$4.74K | 0.04% | 107 |
|
2017
Q1 | $63K | Sell |
963
-100
| -9% | -$6.54K | 0.04% | 115 |
|
2016
Q4 | $67K | Hold |
1,063
| – | – | 0.04% | 112 |
|
2016
Q3 | $67K | Hold |
1,063
| – | – | 0.04% | 107 |
|
2016
Q2 | $66K | Hold |
1,063
| – | – | 0.04% | 107 |
|
2016
Q1 | $61K | Hold |
1,063
| – | – | 0.04% | 111 |
|
2015
Q4 | $63K | Buy |
+1,063
| New | +$63K | 0.06% | 114 |
|